A design for testing interventions to improve adherence within a hypertension clinical trial

Controlled Clinical Trials

Volumn 21, Issue 1, 2000, Pages 62-72

  Johnson, Brian F ^a   Hamilton, Glenys ^a   Fink, Janis ^a   Lucey, Gail ^a   Bennet, Nancy ^a   Lew, Robert ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

Adherence (compliance); Hypertension; Interventions; Oral potassium; Supplementation

Indexed keywords

ANTIHYPERTENSIVE AGENT; PLACEBO; POTASSIUM;

ADULT; AGED; BLOOD PRESSURE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG CAPSULE; DRUG MONITORING; FEMALE; HUMAN; HYPERTENSION; INFORMATION SYSTEM; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PATIENT COMPLIANCE; PATIENT COUNSELING; RANDOMIZED CONTROLLED TRIAL; REVIEW; TELEPHONE;

ADULT; AGED; AGED, 80 AND OVER; DIETARY SUPPLEMENTS; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION; POTASSIUM; RANDOMIZED CONTROLLED TRIALS; REMINDER SYSTEMS; RESEARCH DESIGN; TELEPHONE;

EID: 0033972609     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(99)00049-5     Document Type: Article

References (26)

1. Binstock M.L., Franklin K.L. A comparison of compliance techniques on the control of high blood pressure. Am J Hypertens. 1(3 Pt 3):1988;192S-194S.
2. Champion V.L. Instrument development for health belief model constructs. Adv Nurs Sci. 4:1984;73-85.
3. Champion V.L. The relationship of breast self-examination to health belief model variables. Res Nurs Health. 10:1987;375-382.
4. Gorkin L., Goldstein M.G., Follick M.J., Lefebvre R.C. Strategies for enhancing adherence in clinical trials. Schumaker S.A., Schron E.B., Ockene J.K. The Handbook of Health Behavior Change. 1990;Springer, New York.
5. Cramer J.A. Overview of methods to measure and enhance patient compliance. Cramer J.A., Spilker B. Patient Compliance in Medical Practice and Clinical Trials. 1991;Raven, New York.
6. Levine D.M., Bone L. The impact of a planned health education approach on the control of hypertension in a high risk population. J Hum Hypertens. 4:1990;317-321.
7. Becker M.H. Theoretical models of adherence and strategies for improving adherence. Schumaker S.A., Schron E.B., Ockene J.K. The Handbook of Health Behavior Change. 1990;Springer, New York.
8. Given C.W., Given B.A., Coyle B.W. Prediction of patient attention from experimental behavioral interventions. Nurs Res. 34:1985;293-298.
9. Rosenstock IM. The health belief model and personal health behavior. In: Becker MH, ed. Health Education Monographs. Thorofare, New Jersey: 1974.
10. Jones P.K., Jones S.L., Katz J. Improving follow-up among hypertensive patients using a HBM intervention. Arch Intern Med. 147:1987;1557-1560.
11. Kirscht J.P., Rosenstock I.M. Patient adherence to antihypertensive medical regimens. J Community Health. 3:1977;115-124.
12. Kirscht J.P., Kirscht J.L., Rosenstock I.M. A test of interventions to increase adherence to hypertensive medical regimens. Health Educ Q. 8:1981;261-272.
13. Levine D.M., Green L.W., Deeds S.G.et al. Health education for hypertensive patients. JAMA. 241:1979;1700-1703.
14. Strogatz D.S., Earp J.A.L. The determinants of dropping out of care among hypertensive patients receiving a behavioral interventions. Med Care. 21:1983;970-980.
15. Janz N.K., Becker M.H. The health belief model. A decade later Health Educ Q. 11(1):1984;1-47.
16. MacGregor G.A., Smith S.J., Markandu N.D.et al. Moderate potassium supplementation in essential hypertension. Lancet. 2:1982;567-570.
17. Richards A.M., Nicholls M.G., Espiner E.A.et al. Blood-pressure response to moderate sodium restriction and to potassium supplementation in mild essential hypertension. Lancet. 1:1984;757-761.
18. Matlou S.M., Isles C., Higgs A.et al. Potassium supplementation in Blacks with mild to moderate essential hypertension. J Hypertens. 4:1986;61-64.
19. Siani A., Strazzullo P., Russo L.et al. Controlled trial of long term oral potassium supplements in patients with mild hypertension. Br Med J. 294:1987;1453-1456. [Correction 1987;295:961].
20. Svetkey L.P., Yarger W.E., Feussner J.R.et al. Double-blind, placebo-controlled trial of potassium chloride in the treatment of mild hypertension. Hypertension. 9:1987;444-450.
21. Kaplan N., Carnegie A., Raskin P.et al. Potassium supplementation in hypertensive patients with diuretic-induced hypokalemia. N Engl J Med. 312:1985;746-749.
22. Lumme A.J., Jounela A.J. The effect of potassium and potassium plus magnesium supplementation on ventricular extrasystoles in mild hypertensives treated with hydrochlorothiazide. Int J Cardiol. 25:1989;93-98.
23. Salvetti A., Bichiasao E., Caiazza A.et al. The combination of a Low-Na/High-K salt with Metoprolol in the treatment of mild-moderate hypertension. Am J Hypertens. 1:1988;201S-205S.
24. Suppa G., Pollavini G., Alberti D., Savonitto S., the Italian Group for the Prevention and Care of Arterial Hypertension Effects of a low-sodium high-potassium salt in hypertensive patients treated with metoprolol. J Hypertens. 6:1988;787-790.
25. Grimm Jr R.H., Neaton J.D., Elmer P.J.et al. The influence of oral potassium chloride on blood pressure in hypertensive men on a low-sodium diet. N Engl J Med. 322:1990;569-574.
26. Little R., Yau L. Intent-to-treat analysis for longitudinal studies with drop-outs. Biometrics. 52:1996;1324-1333.